Innovating Works

VPM

Desconocido
CRUZIVAX: Vaccine for prevention and treatment of Trypanosoma cruzi infection VAKZINE PROJEKT MANAGEMENT GMBH participó en un H2020: H2020-SC1-BHC-2018-2020 Chagas is a neglected disease endemic in 21 Latin-American countries caused by Trypanosoma cruzi. It is the largest parasitic disease burden...
2019-04-30 - 2025-02-28 | Financiado
NEWTBVAC: Discovery and preclinical development of new generation tuberculosis vaccines VAKZINE PROJEKT MANAGEMENT GMBH participó en un FP7: With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date. An e...
Financiado
TRANSVAC: European Network of Vaccine Development and Research VAKZINE PROJEKT MANAGEMENT GMBH participó en un FP7: The TRANSVAC infrastructure will accelerate the pharmaceutical and clinical development of promising vaccine candidates by bringing the gap...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.